Lord, Abbett & Co
ALAB icon

Lord, Abbett & Co’s Astera Labs ALAB Stock Holding History

Lord, Abbett & Co’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.9M Buy
200,689
+25,285
+14% +$6.71M 0.28% 101
2026
Q1 		$19.2M Sell
175,404
-767,744
-81% -$109M 0.06% 281
2025
Q4 		$157M Sell
943,148
-553,090
-37% -$92.5M 0.48% 56
2025
Q3 		$293M Sell
1,496,238
-459,812
-24% -$75.6M 0.87% 22
2025
Q2 		$177M Buy
1,956,050
+762,890
+64% +$60.3M 0.57% 44
2025
Q1 		$71.2M Sell
1,193,160
-625,440
-34% -$57.9M 0.25% 112
2024
Q4 		$241M Buy
1,818,600
+1,384,498
+319% +$130M 0.76% 25
2024
Q3 		$22.7M Sell
434,102
-3,740
-0.9% -$176K 0.07% 317
2024
Q2 		$26.5M Sell
437,842
-8,858
-2% -$614K 0.09% 277
2024
Q1 		$33.1M Buy
+446,700
New +$33.1M 0.11% 243

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lord, Abbett & Co's ALAB Position: Q2 2026 in Review

Lord, Abbett & Co increased its Astera Labs (ALAB) stake by 14% in Q2 2026, buying an estimated $6.71M and bringing the position to 200,689 shares worth $96.9M. The position accounts for 0.28% of the portfolio, ranked #101.

Lord, Abbett & Co first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. The position peaked at $293M in Q3 2025. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Lord, Abbett & Co held 200,689 shares of Astera Labs worth $96.9M as of Q2 2026.
  • Lord, Abbett & Co bought 25,285 Astera Labs shares in Q2 2026, an estimated $6.71M.
  • Astera Labs made up 0.28% of Lord, Abbett & Co's portfolio in Q2 2026, its #101 holding.
  • Lord, Abbett & Co first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • Lord, Abbett & Co's Astera Labs position peaked at $293M in Q3 2025.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.